Oxígeno Disuelto: Ley de Henry, Contribución al Contenido de Oxígeno y Relevancia Clínica

El oxígeno disuelto en plasma sigue la ley de Henry: la cantidad de gas disuelto es directamente proporcional a su presión parcial. El coeficiente de solubilidad del oxígeno en plasma a 37°C es 0,003 mL O₂/dL/mmHg. A una PaO₂ normal de 90 mmHg, el oxígeno disuelto contribuye 0,27 mL O₂/dL — menos del 2% del contenido total de oxígeno arterial.

La relación lineal entre PaO₂ y oxígeno disuelto contrasta con la relación sigmoide entre PaO₂ y saturación de hemoglobina. A PaO₂ alta (> 100 mmHg), la hemoglobina está completamente saturada, pero el oxígeno disuelto continúa aumentando linealmente con la PaO₂. El oxígeno suplementario a FiO₂ alta aumenta el CaO₂ principalmente a través del componente disuelto.

The solubility coefficient is temperature-dependent: as temperature decreases, gas solubility in liquids increases according to thermodynamic principles. During therapeutic hypothermia (core temperature approximately 33°C), the oxygen solubility coefficient rises slightly, resulting in marginally higher dissolved oxygen at any given PO₂. Conversely, fever increases body temperature and reduces oxygen solubility, though these changes are quantitatively small (approximately 2% per degree Celsius) and rarely alter clinical decision-making. The 0.003 value used in standard oxygen content equations assumes a body temperature of 37°C, and temperature correction is applied in blood gas analyzers when sample temperature differs from the measurement temperature.

En la oxigenoterapia hiperbárica (HBO a 2–3 atmósferas de O₂ puro), la PaO₂ puede exceder 2.000 mmHg, produciendo un oxígeno disuelto de 6 mL O₂/dL — suficiente para satisfacer las necesidades metabólicas basales sin hemoglobina. Esta es la base del uso de la HBO en la intoxicación por CO y en la anemia extrema cuando la transfusión no está disponible.

En la anemia severa, el oxígeno disuelto se convierte en una fracción proporcionalmente mayor del contenido total de oxígeno. El bypass cardiopulmonar con hemodilución extrema y perfusión hiperóxica utiliza el oxígeno disuelto como mecanismo de transporte complementario importante.

Whether to include the dissolved oxygen term depends on clinical context and desired precision. In routine Fick cardiac output calculations at the catheterization laboratory where PaO₂ is near normal, omitting the dissolved fraction introduces less than 2% error in the final cardiac output value — generally within the measurement uncertainty of VO₂ and saturation determinations. However, when patients are receiving high FiO₂ resulting in PaO₂ values above 300 mmHg, or when hyperbaric conditions are present, the dissolved fraction becomes large enough that its omission would introduce clinically meaningful error. Best practice is to always include the term for maximal accuracy.

Incluir el término de oxígeno disuelto (0,003 × PO₂) en los cálculos de contenido de oxígeno mejora marginalmente la precisión en condiciones normales pero puede ser significativo en la oxigenoterapia hiperbárica, el bypass cardiopulmonar hiperóxico y la anemia extrema. Muchas calculadoras simplifican omitiendo el término disuelto, introduciendo un error < 2% en la mayoría de los escenarios clínicos.

La decisión de incluir u omitir el oxígeno disuelto debe basarse en el contexto clínico y la precisión requerida. Para evaluaciones hemodinámicas de rutina, la omisión es aceptable. Para investigación o escenarios con PaO₂ muy alta o hemoglobina muy baja, la inclusión del componente disuelto es recomendada.

Extreme hyperoxia — deliberately achieved in certain research protocols and select critical care scenarios — also elevates dissolved oxygen substantially. Patients on extracorporeal membrane oxygenation (ECMO) can achieve PaO₂ values of 300–500 mmHg, and the dissolved oxygen contribution should be included in oxygen content and delivery calculations for accurate hemodynamic profiling. Additionally, during cardiopulmonary bypass with hyperoxic perfusion, the dissolved fraction can contribute meaningfully to total oxygen delivery, particularly during hypothermic conditions when metabolic demand is reduced and the additional dissolved oxygen may exceed tissue requirements even with reduced hemoglobin concentrations from hemodilution.

Modern blood gas analyzers measure PaO₂ directly using a Clark-type polarographic oxygen electrode, which generates a current proportional to the partial pressure of dissolved oxygen in the blood sample. The PaO₂ value reported on a blood gas result reflects only the dissolved fraction — it does not indicate how much oxygen is bound to hemoglobin. A normal PaO₂ of 80–100 mmHg on room air indicates adequate alveolar gas exchange, but without concurrent hemoglobin and saturation data, PaO₂ alone cannot define total oxygen content. This is why comprehensive hemodynamic assessment requires a full blood gas panel including co-oximetry and hemoglobin measurement.

The alveolar-arterial oxygen gradient (A-a gradient) is calculated using PaO₂ and provides a measure of gas exchange efficiency that is directly relevant to dissolved oxygen. A widened A-a gradient indicates impaired oxygen transfer across the alveolar-capillary membrane, as seen in pulmonary embolism, pneumonia, or interstitial lung disease, which reduces PaO₂ and therefore reduces the dissolved oxygen contribution to CaO₂. The A-a gradient is calculated as: A-a gradient = [FiO₂ × (Patm − PH₂O) − (PaCO₂ ÷ RQ)] − PaO₂, where Patm is atmospheric pressure, PH₂O is water vapor pressure (47 mmHg at 37°C), and RQ is the respiratory quotient (typically 0.8). A normal A-a gradient for a young adult breathing room air is approximately 5–15 mmHg and increases with age.